CARsgen Therapeutics Announces 2025 Interim Results

ESMO Preview | CARsgen to Present Results on Satri-cel for Adjuvant Therapy of Pancreatic Cancer at ESMO Congress 2025

CARsgen Successfully Defends Its GPC3 CAR-T Patent at the EPO

CARsgen Therapeutics Announces NDA Acceptance of Satri-cel by China’s NMPA

CARsgen Therapeutics Submits New Drug Application for Satri-cel to China’s NMPA

CARsgen Presents Results of GPRC5D CAR-T CT071 at EHA 2025

CARsgen Presents Research Results on Satri-cel in The Lancet and at the 2025 ASCO Annual Meeting

CARsgen’s Satri-cel Granted Priority Review by the NMPA

CARsgen’s Satri-cel Abstract Available on ASCO Website

CARsgen’s CT071 Abstract Published on EHA Website